Sexual delinquency and Parkinson's disease;Sexuelle delinquenz und morbus Parkinson

Nervenarzt

Volumn 74, Issue 4, 2003, Pages 370-375

  Berger, Ch ^a   Mehrhoff, F W ^b   Beier, K M ^c   Meinck, H M ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Deutsche Parkinson Vereinig B eV   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Dopamine agonists; L dopa; Parkinson's disease; Sexual delinquency

Indexed keywords

BROMOCRIPTINE; LEVODOPA; ROPINIROLE;

ADULT; ARTICLE; CASE REPORT; DOPAMINERGIC SYSTEM; EXHIBITIONISM; FORENSIC MEDICINE; GERMANY; HUMAN; LIBIDO DISORDER; MALE; PARKINSON DISEASE; PEDOPHILIA; SEXUAL BEHAVIOR; SEXUAL CRIME; SEXUAL DEVIATION;

ANTIPARKINSON AGENTS; AWARENESS; BROMOCRIPTINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EXHIBITIONISM; EXPERT TESTIMONY; HUMANS; IMPULSIVE BEHAVIOR; INDOLES; LEVODOPA; LIBIDO; MALE; MIDDLE AGED; PARKINSON DISEASE; PEDOPHILIA; SEX OFFENSES;

EID: 0037508552     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-003-1505-6     Document Type: Article

References (32)

1. Beier KM, Bosinski HAG, Hartmann U, Loewit K (2001) Sexualmedizin Grundlagen und Praxis. Urban und Fischer, München
2. Beier KM, Luders M, Boxdorfer SA (2000) Sexuality and partnership aspects of Parkinson disease Results of an empirical study of patients and their partners. Fortschr Neurol Psychiatr 68: 564-575
3. Bowers MB Jr, Van Woert M, Davis L (1971) Sexual behavior during L-Dopa treatment for Parkinsonism. Am J Psychiatry 127: 1691-1693
4. Brown RG, Jahanshahi M, Quinn N, Marsden CD (1990) Sexual function in patients with Parkinson's disease and their partners. J Neurol Neurosurg Psychiatry 53: 480-486
5. Burguera JA, Garcia Reboll L, Martinez Agullo E (1994) Sexual dysfunction in Parkinson's disease. Neurologia 9: 178-181
6. Courty E, Durif F, Zenut M, Courty P, Lavarenne J (1997) Psychiatric and sexual disorders induced by apomorphine in Parkinson's disease. Clin Neuropharmacol 20: 140-147
7. Cummings JL (1991) Behavioral complications of drug treatment of Parkinson's disease. J Am Geriatr Soc 39: 708-716
8. Factor SA, Molho ES, Podskalny GD, Brown D (1995) Parkinson's disease: drug-induced psychiatric states. Adv Neurol 65: 115-138
9. Golbe LI (1991) Young-onset Parkinson's disease: a clinical review. Neurology 41: 168-173
10. Hyyppa M, Rinne UK, Sonninen V (1970) The activating effect of L-Dopa treatment on sexual functions and its experimental background. Acta Neurol Scand Suppl 43: 223
11. Jacobs H, Vieregge A, Vieregge P 2000 Sexuality in young patients with Parkinson's disease: a population based comparison with healthy controls. J Neurol Neurosurg Psychiatry 69: 550-552
12. Jeschek HH (1988) Lehrbuch des Strafrechts Allgem. Teil. 4. Aufl. Duncker & Humblot, Berlin, pp 394
13. Jeschek HH (1988) Lehrbuch des Strafrechts Allgem. Teil. 4. Aufl. Duncker & Humblot, Berlin, pp 397
14. Koller WC, Vetere-Overfield B, Williamson A, Busenbark K, Nash J, Parrish D (1990) Sexual dysfunction in Parkinson's disease. Clin Neuropharmacol 13: 461-463
15. Krueger RB, Kaplan MS (2000) Disorders of sexual impulse control in neuropsychiatric conditions. Semin Clin Neuropsychiatry 5: 266-274
16. Lambert D, Waters CH (1998) Sexual dysfunction in Parkinson's disease. Clin Neurosci 5: 73-77
17. Melamed E, Friedberg G, Zoldan J (1999) Psychosis: impact on the patient and family. Neurology 52: S14-16
18. Namer M (1988) Clinical applications of anti-androgens. J Steroid Biochem 31: 719-729
19. O'Sullivan JD, Hughes AJ (1998) Apomorphine-induced penile erections in Parkinson's disease. Mov Disord 13: 536-539
20. Quinn NP, Toone B, Lang AE, Marsden CD, Parkes JD (1983) Dopa dose-dependent sexual deviation. Br J Psychiatry 142: 296-298
21. Rauschelbach HH, Jochheim KA, Widder B (2000) Das neurologische Gutachten. 4. Aufl. Thieme, Stuttgart New York
22. Romito LM, Scerrati M, Contarino MF, Bentivoglio AR, Tonali P, Albanese A (2002) Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology 58: 1546-1550
23. Roxin C (1992) Strafrecht Allgemeiner Teil. Bd1 § 20 A I 9558. Beck, München
24. Roxin C (1992) Strafrecht Allgemeiner Teil, Bd1 § 20 Rdw 32. Beck, München
25. Ruggieri S, De Pandis MF, Bonamartini A, Vacca L, Stocchi F (1997) Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease. Clin Neuropharmacol 20: 204-209
26. Sakakibara R, Shinotoh H, Uchiyama T, Sakuma M, Kashiwado M,Yoshiyama M, Hattori T (2001) Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Auton Neurosci 92: 76-85
27. Schönke A, Schröder H (2001) Strafgesetzbuchkommentar. 26. Aufl. § 20 Rdw 29-11. Beck, München
28. Trosch RM, Friedman JH, Lannon MC et al. (1998) Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience. Mov Disord 13: 377-382
29. Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B 81989) Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 12: 375-383
30. Vogel HP, Schiffter R (1983) Hypersexuality a complication of dopaminergic therapy in Parkinson's disease. Pharmacopsychiatria 16: 107-110
31. Welsh M, Hung L, Waters CH (1997) Sexuality in women with Parkinson's disease. Mov Disord 12: 923-927
32. Wermuth L, Stenager E (1995) Sexual problems in young patients with Parkinson's disease Acta Neurol Scand 91: 453-455